Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis
-
Published:2024-07-05
Issue:
Volume:
Page:
-
ISSN:1936-0533
-
Container-title:Hepatology International
-
language:en
-
Short-container-title:Hepatol Int
Author:
Lv Gui-Ji, Ji Dong, Yu Lingxiang, Chen Hong-Yan, Chen Jing, He Mengwen, Wang Wen-Chang, Wang Hong-Bo, Tsang Christopher, Wang Jianjun, Yu Ming-Lung, Lau GeorgeORCID, Lau GeorgeORCID, Omaya Masao, Jia Jidong, Zhuang Hui, Wen Yu-Mei, Zhang Xinxin, Yang Jin Mo, Tanwandee Tawesak, Payawal Diana, Hamid Saeed, Sarin S. K., Chen Jing, Ji Dong, Zhang Wenhong, Wang Fusheng, Fan Jiangao, Lu Lungen, Dou Xiaoguang, Qi Xiaolong, Ning Qin, You Hong, Ren Hong, Sun Jian, Yu Ming-Lung, George Jacob, Goh George B. B., Ahn Sang Hoon, Gani Rino Alvani, Merican Mohd Ismail, Win Khin Maung, Baatarkhuu Oidov, Ghazinyan Hasmik, El-Sayed Manal H., Chutaputti Anuchit, Charatcharoenwitthaya Phunchai, Chen Pei-jer, Kao Jia-Horng, Mohamed Rosmawati, Maiwall Rakhi, Kumar Manoj, Aggarwal Rakesh, Thompson Alexander, Kim Yoon Jun, Wong Grace, Gao Fu, Li Gang, Niu Jun-Qi, Wang Yu, Gao Zhi-Liang,
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https://doi.org/10.3322/caac.21834 2. WHO Global progress report on HIV, viral hepatitis and sexually transmitted infections. Accountability for the global health sector strategies 2016–2021: actions for impact[M]. Geneva: World Health Organization; 2021. p. 2021 3. Khatun M, Ray R, Ray RB. Hepatitis C virus associated hepatocellular carcinoma. Adv Cancer Res. 2021;149:103–142 4. Ji F, Yeo YH, Wei MT, Ogawa E, Enomoto M, Lee DH, et al. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatol. 2019;71(3):473–485 5. Tsai PC, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, et al. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan. J Hepatol. 2023;78(2):281–292
|
|